Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Researchers at the University of Oxford have developed a mindfulness training specifically for people with irritable bowel syndrome.

We are interested in finding out if this training is effective at reducing the symptoms of IBS and how the training achieves its effects. Interested? Please keep on reading to find out what is involved for you:

What is involved?

  • A six week mindfulness course
  • Regular study assessments

About the mindfulness course

Mindfulness for IBS is a new mindfulness course specifically for people with irritable bowel syndrome. The course consists of 6 x 2 hour group sessions over 6-7 weeks. During the course you will develop awareness of your mind and body through the cultivation of mindful awareness. The aim of the course is to reduce the symptoms of IBS and help you increase your mental and physical wellbeing.

Study Participation: The course is provided at no cost to you as participant

About the assessments

You will be asked to do 3 assessment visits at the Department of Experimental Psychology and 4-8 online questionnaires before, during and after the course. Each assessment visit takes 1-1.5 hours. Each questionnaire takes 30-45 minutes.

Are you eligible? 

  • Do you have a diagnosis of IBS?
  • Are you interested in trying mindfulness as a treatment for IBS?
  • Are you a woman between 18 and 65 years of age?

Location

Course: Oxford Mindfulness Centre, Oxford University

Assessments: Department of Experimental Psychology, Oxford University

Dates and Registration

To find out more about the study, when the courses take place and to register, please contact Julia Henrich via email Julia.Henrich@psy.ox.ac.uk.

You can also sign up online.

 

NHS REC Reference: REC: South Central – Oxford A, 15/SC/0618

Similar stories

Young lives under pressure as global crises hits mental health and well-being – report

The well-being and mental health of young people in low - and middle - income countries have been dramatically affected by the series of crises hitting the world. As the international community continues to struggle with the impact of COVID-19, conflict and climate change, the latest report from the Young Lives project shows a long-running upward trend in young people’s well-being has been sharply reversed alongside widespread anxiety and depression. Young people are less confident about their futures for the first time in the 20-year study.

Bacterial infections linked to one in eight global deaths, according to GRAM study

Data showing 7.7 million deaths from 33 bacterial infections can guide measures to strengthen health systems, particularly in low-income settings

New tool aims to make bowel cancer treatments more effective

The Leedham Lab in Nuffield Department of Medicine (NDM) has been awarded over £2M from Cancer Research UK to develop a new tool that could help guide how bowel cancer patients are treated in the future.

Doug Higgs awarded the 2023 Genetics Society Medal

The award recognises Radcliffe Department of Medicine's Professor Higgs major contribution to our understanding of how mammalian genes are switched on and off, and using haematopoiesis as a model to understand how genes function.

First evidence drug resistant bacteria can travel from gut to lung, increasing infection risks

A new Oxford University study released during World Antimicrobial Awareness Week has significant findings on how antimicrobial resistance (AMR) arises and persists. The results, published today in Nature Communications, provide the first direct evidence of AMR bacteria migrating from a patient’s gut microbiome to the lungs, increasing the risk of deadly infections.